Clinical Trials Directory

Trials / Completed

CompletedNCT03695432

Probiotic and Influenza Vaccination to Reducing Influenza-like Illness Incident in Elderly

Role of Probiotic and Influenza Vaccination on Immune Response Enchancement and Influenza-Like Illness Incidence Reduction in Elderly

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
910 (actual)
Sponsor
Indonesia University · Academic / Other
Sex
All
Age
60 Years – 90 Years
Healthy volunteers
Accepted

Summary

To asses the effect of the probiotic and influenza vaccination alone and combination on enhancing immune response to influenza-like illness (ILI) and reducing ILI incidence in the elderly

Detailed description

To see percetange of subjects seroconvertion and seroprotection before and after intervention in the elderly (\>60 years), and monitored for 6 months.

Conditions

Interventions

TypeNameDescription
BIOLOGICALFlubioFlubio (A/California/7/2009, A/Texas/50/2012 and B/Massachusetts/2/2012) Vaccine 0,5 ml for every subjects The vaccine will be given intramuscularly
DIETARY_SUPPLEMENTLacidofilLacidofil (Lactobacillus acidophilus Rossel-52 and Lactobacillus rhamnosus Rosell-11 with maltodextrin 211 mg, magnesium stearat 8 mg and ascorbic acid 1 mg) antibiotic The antibiotic will be given 2 times each day for 6 months
OTHERPlacebo VaccineNacl 0,9% 0,5 ml The placebo vaccine will be given intramuscularly
OTHERPlacebo probioticCapsul

Timeline

Start date
2014-10-01
Primary completion
2015-04-01
Completion
2016-07-01
First posted
2018-10-04
Last updated
2018-10-05

Locations

1 site across 1 country: Indonesia

Source: ClinicalTrials.gov record NCT03695432. Inclusion in this directory is not an endorsement.